We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
751
Ready Capital Corp 6.25% Series C Preferred Stock
RC.PRC
$3.35M
| $35K | ﹤0.01% |
1,800
| – | – |
2022 Q1
7 quarters
|
|
752
Teradata
TDC
$3.02B
| $35K | ﹤0.01% |
800
| – | – |
2022 Q1
7 quarters
|
|
753
Universal Insurance Holdings
UVE
$1.33B
| $35K | ﹤0.01% |
2,200
| – | – |
2023 Q2
2 quarters
|
|
754
NCR Voyix
VYX
$1.14B
| $35K | ﹤0.01% |
2,054
-1,294
| -39% | -$20.6K |
2022 Q1
7 quarters
|
|
755
abrdn Healthcare Investors
HQH
$1.16B
| $34K | ﹤0.01% |
2,024
| – | – |
2022 Q1
7 quarters
|
|
756
iShares Expanded Tech Sector ETF
IGM
$10.9B
| $34K | ﹤0.01% |
450
| – | – |
2022 Q1
7 quarters
|
|
757
Rambus
RMBS
$10B
| $34K | ﹤0.01% |
500
| – | – |
2022 Q1
7 quarters
|
|
758
Trane Technologies
TT
$102B
| $34K | ﹤0.01% |
141
| – | – |
2022 Q2
6 quarters
|
|
759
Marriott Vacations Worldwide
VAC
$3.9B
| $34K | ﹤0.01% |
394
| – | – |
2022 Q1
7 quarters
|
|
760
DELISTED
Berry Global Group, Inc.
BERY
| $34K | ﹤0.01% |
545
| – | – |
2023 Q2
2 quarters
|
|
761
Arcosa
ACA
$7.24B
| $33K | ﹤0.01% |
399
| – | – |
2023 Q2
2 quarters
|
|
762
Centene
CNC
$35B
| $33K | ﹤0.01% |
452
| – | – |
2022 Q1
7 quarters
|
|
763
Capital One
COF
$124B
| $33K | ﹤0.01% |
248
+218
| +727% | +$23.5K |
2023 Q3
1 quarter
|
|
764
Cenovus Energy
CVE
$61.2B
| $33K | ﹤0.01% |
2,000
| – | – |
2022 Q1
7 quarters
|
|
765
Denali Therapeutics
DNLI
$3.03B
| $33K | ﹤0.01% |
1,500
-23,300
| -94% | -$461K |
2020 Q4
12 quarters
|
|
766
Eastman Chemical
EMN
$7.26B
| $33K | ﹤0.01% |
360
| – | – |
2022 Q1
7 quarters
|
|
767
DELISTED
Hologic
HOLX
| $33K | ﹤0.01% |
+460
| New | +$32K |
2023 Q4
0 quarters
|
|
768
Piper Sandler
PIPR
$4.53B
| $33K | ﹤0.01% |
744
| – | – |
2022 Q1
7 quarters
|
|
769
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.95B
| $32K | ﹤0.01% |
978
+947
| +3,055% | +$29K |
2023 Q3
1 quarter
|
|
770
MillerKnoll
MLKN
$1.46B
| $32K | ﹤0.01% |
1,200
| – | – |
2022 Q1
7 quarters
|
|
771
Invesco International Dividend Achievers ETF
PID
$881M
| $32K | ﹤0.01% |
1,722
+1,667
| +3,031% | +$28.5K |
2023 Q3
1 quarter
|
|
772
iShares ESG Screened S&P Mid-Cap ETF
XJH
$409M
| $32K | ﹤0.01% |
850
| – | – |
2022 Q1
7 quarters
|
|
773
DELISTED
Hawaiian Holdings, Inc.
HA
| $32K | ﹤0.01% |
2,200
| – | – |
2022 Q1
7 quarters
|
|
774
Allstate Corp
ALL.PRH
$836M
| $31K | ﹤0.01% |
1,396
+496
| +55% | +$10.3K |
2022 Q1
7 quarters
|
|
775
First Trust Health Care AlphaDEX Fund
FXH
$1.14B
| $31K | ﹤0.01% |
300
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.